Peer-reviewedCC BYFrontiers in pharmacology
Traditional Chinese medicine (TCM)-based nanoformulations for cancer therapy: antitumor mechanisms, challenges, and future directions
- 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , , ,
- 2Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan University , ,
Related
- Brain-computer interfaces in pediatric populations: research advances, application challenges, and future directions
- The potential biomarkers of organ transplantation in the era of machine perfusion: Current status, challenges, and future directions
- Artificial Intelligence in Emergency Radiology: Current Applications, Challenges, and Future Directions.
- Antibody–drug conjugates in solid tumors: current landscape, challenges, and future directions
- Transcatheter Mitral Valve Replacement: Clinical Challenges, Evolving Indications, and Future Directions.
BibTeX
@article{yang2026traditional,
title = {{Traditional Chinese medicine (TCM)-based nanoformulations for cancer therapy: antitumor mechanisms, challenges, and future directions}},
author = {Xiaoyu Yang and Shuailong Jia and Meiling Wu and Yi Zhou},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655532},
note = {CC BY},
}
RIS
TY - JOUR
TI - Traditional Chinese medicine (TCM)-based nanoformulations for cancer therapy: antitumor mechanisms, challenges, and future directions
AU - Xiaoyu Yang
AU - Shuailong Jia
AU - Meiling Wu
AU - Yi Zhou
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13655532
SN - 1663-9812
ER -